Management of High Blood Pressure in Peripheral Arterial Disease

References

• Aronow W., Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women a 62 years of age. Am J Cardiol, 1994, 74: 64–5.
   Google Scholar
• Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med, 2003, 163: 884–92.
   Google Scholar
• Kannel W. B. Risk stratification in hypertension: new insights from the Framingham Study. Am JHypertens, 2000, 13: 3s-10s.
   Google Scholar
• Murabito J., Evans J., Nieto K., Larson M., Levy D., Wilson P. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J, 2002, 143: 961–5.
   Google Scholar
• Kannel W. B. Potency of vascular risk factors as the basis for antihypertensive therapy. Eur Heart J, 1992, suppl G: 34–42.
   Google Scholar
• Dormandy J. A., Heeck L., Vig S. The fate of patients with critical leg ischemia. Seminar Vasc Drug, 1999, 12: 142–7.
   Google Scholar
• Möhler E. R. Peripheral arterial disease: identification and implications. Arch Intern Med, 2003, 163: 2306–14.
   Google Scholar
• Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 2001, 285: 2486–97.
   Google Scholar
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation, 2002, 106: 3145–421.
   Google Scholar
• European Group for the study of Insulin Resistance (EGIR) Diabetes Metab, 2002, 28: 364–76.
   Google Scholar
• Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens, 2003, 21: 1011–53.
   Google Scholar
• Olijhoek J., van der Graaf Y., Banga J.-D. et al. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J, 2004, 25: 342–8.
   Google Scholar
• Chen J., Muntner P., Hamm L. L. et al. Association of the metabolic syndrome and chronic kidney disease in U.S. adults. Ann Int Med, 2004, 140: 167–74.
   Google Scholar
• O’Hare A., Glidden D., Fox C., Hsu C. Y. High Prevalence of peripheral arterial disease in persons with renal insufficiency. Circulation, 2004, 109: 320–3.
   Google Scholar
• Garcia De Vinuesa S., Ortega M., Martinez P., Goicoechea M., Gomez Campdera F., Luño J. Subclinical peripheral arterial disease in patients with chronic kidney disease: prevalence and related risk factors. Kidney Int, 2005, 67: S44–7.
   Google Scholar
• Gagnon F., Dagenais G., Robitaille N. M., Lupien P. J. Impact of systolic and diastolic blood pressure on ischaemic vascular diseases in French-Canadian men from 1974 to 1990. Can J Cardiol, 1994, 10: 97–105.
   Google Scholar
• Vogt M. T., Wolfson S. K., Kuller L. M. Segmental arterial disease in the lower extremities. Correlates of disease and relationship to mortality. J Clin Epidemiol, 1993, 46: 1267–76.
   Google Scholar
• Safar M. Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors. Curr Opin Nephrol Hypertens, 2001, 10: 257–61.
   Google Scholar
• Newman A. B., Stutton-Tyrrell K., Rutan G., Locher J., Kuller L. H. Lower extremities arterial disease in elderly subjects with systolic hypertension. J Clin Epidemiol, 1991, 44: 15–20.
   Google Scholar
• Newman A., Sutton-Tyrrell K., Vogt M., Kuller L. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA, 1993, 270: 487–9.
   Google Scholar
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med, 1997, 157: 2413–45.
   Google Scholar
• Chobanian A., Bakris G., Black H. et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 report. JAMA, 2003, 289: 2560–72.
   Google Scholar
• Mehler P., Coll J., Estacio R., Esler A., Schrier R., Hiatt W. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation, 2003, 107: 753–6.
   Google Scholar
• Gates P. E., Tanaka H., Hiatt W. R., Seals D. R. Dietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertension. Hypertension, 2004, 44: 35–41.
   Google Scholar
• UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ, 1998, 317: 703–13.
   Google Scholar
• Bogaert M. G., Clement D. L. Lack of influence of propanolol and metoprolol on walking distance inpatients with chronic intermittent claudication. Eur Heart J, 1983, 4: 203–4.
   Google Scholar
• Solomon S. A., Ramsay L. E., Yeo W. W., Parnell L., Moris-Jones W. Beta-blockade and intermittent claudication: placebo controlled comparison of atenolol and nifedipine and their combinations. BMJ, 1991, 303: 1100–4.
   Google Scholar
• Hirsch A. T., Duprez D. The potential role of angiotensin-con-verting enzyme inhibition in peripheral arterial disease. Vasc Med, 2003, 8: 273–8.
   Google Scholar
• The Heart Outcomes Prevention Evaluation Study investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med, 2000, 342: 145–53.
   Google Scholar
• Shurrab A. E., MacDowall P., Wright J., Mamtora H., Kalra P. A. The importance of associated extra-renal vascular disease on the outcome of patients with atherosclerotic renovascular disease. Nephrol Clin Pract, 2003, 93: c51–7.
   Google Scholar
• Olin J. W., Melia M., Young J. R., Graor R. A., Risius B. Prevalence of atherosclérotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med, 1990, 88: 46N–51N.
   Google Scholar
• Julius S., Kjeldsen S., Weber M. et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet, 2004, 363: 2022–31.
   Google Scholar
• Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, palceob-controlled, multicentre trial (the EUROPA study). Lancet, 2003, 362: 782–8.
   Google Scholar
• Dahlöf B., Devereux R. B., Kjeldsen S. E. et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE) study: a randomised trial against atenolol. Lancet, 2002, 359: 995–1003.
   Google Scholar
• Kjeldsen S., Dahlöf B., Devereux R. et al. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy. A Losartan Intervention For Endpoint reduction (LIFE) substudy. JAMA, 2002, 288: 1491–8.
   Google Scholar
• Erkens J., Klungel O., Stolk R., Spoelstra J., Grobbee D., LEUFKENS H. Antihypertensive drug therapy and the risk of lower extremity amputations in pharmacologically treated type 2 diabetes patients. Pharmacoepidemiology Drug Safety, 2004, 13: 139–46.
   Google Scholar
• Sever P., Dahlöf B., Poulter N. et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet, 2003, 361: 1149–58.
   Google Scholar